Skip to main content
    F

    Femasys Inc (FEMY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $1.28
    -0.14 (-9.86%)

    Market Cap: $11.89M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Femasys Inc (FEMY) Financials: Revenue, Profit and Cash Flow

    Updated Nov 13, 2026. Financial statements from company filings, amounts in US dollars.

    Femasys reported revenue of $2.29M for the fiscal year ended Dec 31, 2025, up 40.8% from the year before. That year, net income was -$18.63M with a net margin of -812.3%, operating cash flow was -$18.69M and free cash flow was -$19.22M. The quarter ended Sep 30, 2026 had revenue of $404.60K and net income of -$4.56M.

    Revenue and Margins

    Over the 6 years to Dec 2025, revenue grew from $929.06K, a compound annual rate of 16.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.29M+40.8%62.0%-767.0%-812.3%
    Dec 2024$1.63M+52.0%66.6%-1091.8%-1155.0%
    Dec 2023$1.07M-11.1%64.5%-1353.4%-1329.1%
    Dec 2022$1.21M+2.2%63.4%-961.7%-944.6%
    Dec 2021$1.18M+13.7%68.6%-706.7%-639.0%
    Dec 2020$1.04M+11.7%70.5%-668.0%-666.2%
    Dec 2019$929.06KN/A75.9%-1252.6%-1213.3%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$2.29M$1.63M$1.07M$1.21M$1.18M$1.04M$929.06K
    Cost of revenue$872.40K$544.90K$380.07K$441.94K$370.38K$306.53K$223.68K
    Gross profit$1.42M$1.08M$691.90K$764.28K$809.30K$731.38K$705.39K
    Research and development$7.58M$8.22M$7.21M$5.81M$4.08M$4.13M$6.91M
    Operating income-$17.59M-$17.79M-$14.51M-$11.60M-$8.34M-$6.93M-$11.64M
    Net income-$18.63M-$18.82M-$14.25M-$11.39M-$7.54M-$6.91M-$11.27M
    EBITDA-$14.60M-$15.72M-$13.49M-$10.71M-$6.55M-$5.82M-$10.16M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$404.60K$331.83K$424.89K$813.39K$729.39K$409.27K$341.26K$581.58K$554.91K$221.48K$271.14K$213.11K
    Gross profit$217.10K$189.39K$266.28K$510.26K$435.56K$251.10K$224.00K$389.17K$364.07K$148.36K$182.61K$134.82K
    Operating income-$4.45M-$5.07M-$4.22M-$4.62M-$3.65M-$3.85M-$5.46M-$4.72M-$5.12M-$4.48M-$3.46M-$4.45M
    Net income-$4.56M-$4.47M$846.10K-$3.95M-$4.19M-$4.59M-$5.90M-$5.12M-$5.41M-$4.68M-$3.60M-$4.41M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $3.18M by $6.09M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$20.72M$12.45M$27.76M$16.90M$28.58M$7.61M$12.65M
    Current assets$16.46M$8.02M$23.18M$14.13M$25.63M$3.86M$8.04M
    Cash and equivalents$9.27M$3.45M$21.72M$12.96M$24.78M$3.32M$6.42M
    Total liabilities$14.85M$10.14M$9.40M$1.65M$2.24M$4.08M$58.02M
    Short-term debt$0$5.41M$0$141.30K$181.12K$630.01K$467.70K
    Long-term debt$3.18M$0$4.26M$0N/A$182.49KN/A
    Shareholder equity$5.87M$2.30M$18.35M$15.24M$26.33M-$51.82M-$45.37M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$35.09M$12.29M$16.50M$20.72M$16.29M$13.78M$13.28M$12.45M$15.59M$20.28M$24.37M$27.76M
    Total liabilities$8.06M$8.26M$9.21M$14.85M$11.73M$12.27M$11.28M$10.14M$9.62M$9.03M$8.76M$9.40M
    Cash and equivalents$23.91M$1.44M$5.39M$9.27M$4.57M$3.22M$3.82M$3.45M$7.61M$13.53M$17.84M$21.72M
    Shareholder equity$27.03M$4.03M$7.29M$5.87M$4.56M$1.51M$2.00M$2.30M$5.97M$11.25M$15.61M$18.35M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$18.69M-$19.44M-$11.28M-$10.73M-$7.93M-$4.93M-$11.01M
    Capital expenditures$525.01K$761.71K$143.92K$407.48K$306.87K$8.35K$696.50K
    Free cash flow-$19.22M-$20.21M-$11.42M-$11.14M-$8.24M-$4.94M-$11.70M
    Share repurchases$1.74M$0$229.95K$232.84K$1.58M$75.00KN/A
    Investing cash flow-$630.10K-$847.76K-$143.92K-$407.48K-$306.87K$968.32K$12.32M
    Financing cash flow$25.14M$2.03M$20.18M-$681.64K$29.70M$871.65K-$127.78K
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$4.82M-$3.94M-$4.14M-$4.19M-$5.39M-$4.35M-$4.77M-$5.07M-$5.47M-$4.33M-$4.57M-$3.04M
    Capital expenditures$17.51K$9.40K$79.14K$139.84K$194.33K$94.23K$96.61K$106.79K$407.94K$182.42K$64.56K$44.90K
    Free cash flow-$4.84M-$3.95M-$4.22M-$4.33M-$5.58M-$4.45M-$4.86M-$5.18M-$5.88M-$4.51M-$4.63M-$3.08M
    Last 12 quarters

    Frequently Asked Questions About FEMY

    What is Femasys' annual revenue?

    Femasys reported revenue of $2.29M for the fiscal year ended Dec 31, 2025.

    How fast is Femasys' revenue growing?

    Revenue was up 40.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 23.9%.

    Is Femasys profitable?

    No. Femasys reported net income of -$18.63M for the fiscal year ended Dec 31, 2025, with a net margin of -812.3%.

    How much free cash flow does FEMY generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$18.69M minus capital expenditures of $525.01K produced free cash flow of -$19.22M.

    How much debt does Femasys have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $3.18M, short-term debt of $0 and cash and equivalents of $9.27M.